{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:52:33Z","timestamp":1781668353771,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Mutations in the\n                      <jats:italic>Four-and-a-Half LIM Domains 1<\/jats:italic>\n                      (\n                      <jats:italic>FHL1<\/jats:italic>\n                      ) gene are increasingly recognized as a rare cause of inherited cardiomyopathies, often associated with skeletal myopathy and adverse cardiac outcomes. The phenotypic spectrum and clinical implications of\n                      <jats:italic>FHL1<\/jats:italic>\n                      variants remain poorly defined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To systematically review published cases of\n                      <jats:italic>FHL1<\/jats:italic>\n                      -related cardiomyopathy and characterize the clinical, genetic, and pathological features.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a systematic literature search in PubMed and EMBASE up to July 2025 using predefined criteria to identify studies reporting clinical cases of patients with\n                      <jats:italic>FHL1<\/jats:italic>\n                      mutations and cardiac involvement. Data on genotype, phenotype, cardiac and neuromuscular features, and clinical outcomes were extracted and synthesized.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-two studies were included, comprising 114 patients with pathogenic or likely pathogenic\n                      <jats:italic>FHL1<\/jats:italic>\n                      mutations. Most patients were male (69%), with a median age of onset of 18 (IQR 10\u201326) years. Cardiac involvement consisted in left ventricular hypertrophy (56%), followed by arrhythmias (51%), and conduction abnormalities (8%). The incidence of sudden cardiac death was 7%, and heart transplantation was reported in 5% of patients. Skeletal muscle involvement was present in 75%, ranging from mild contractures to more severe myopathic phenotypes with functional impairment. Creatine kinase levels were variably elevated. Truncating variants were reported in several severe cardiac presentations in young males, while isolated cardiac disease occurred with selected variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>FHL1<\/jats:italic>\n                      -related cardiomyopathy is a rare but important diagnosis. Genetic testing should be considered in patients with cardiac hypertrophy and neuromuscular features. Further research is needed to define prognostic markers and guide management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-06096-x","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:36:05Z","timestamp":1781663765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical spectrum, cardiac phenotypes, and outcomes of FHL1-related cardiomyopathies: a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"Emanuele","family":"Bobbio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Pisacane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Viscovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Monda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"De Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Losi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bossone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet Nee","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Frisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"4","key":"6096_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nmd.2011.01.001","volume":"21","author":"BS Cowling","year":"2011","unstructured":"Cowling BS, Cottle DL, Wilding BR, D\u2019Arcy CE, Mitchell CA, McGrath MJ Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord. 2011;21(4):237\u201351. https:\/\/doi.org\/10.1016\/j.nmd.2011.01.001.","journal-title":"Neuromuscul Disord"},{"issue":"14","key":"6096_CR2","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/hmg\/dds157","volume":"21","author":"FW Friedrich","year":"2012","unstructured":"Friedrich FW, Wilding BR, Reischmann S, Crocini C, Lang P, Charron P, et al Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet. 2012;21(14):3237\u201354. https:\/\/doi.org\/10.1093\/hmg\/dds157.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"6096_CR3","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.1074\/jbc.M512552200","volume":"281","author":"MJ McGrath","year":"2006","unstructured":"McGrath MJ, Cottle DL, Nguyen MA, Dyson JM, Coghill ID, Robinson PA, et al Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly. J Biol Chem. 2006;281(11):7666\u201383. https:\/\/doi.org\/10.1074\/jbc.M512552200.","journal-title":"J Biol Chem"},{"key":"6096_CR4","doi-asserted-by":"publisher","first-page":"149468","DOI":"10.1016\/j.bbrc.2024.149468","volume":"694","author":"T Qi","year":"2024","unstructured":"Qi T, Zhang J, Zhang K, Zhang W, Song Y, Lian K, et al Unraveling the role of the FHL family in cardiac diseases: Mechanisms, implications, and future directions. Biochem Biophys Res Commun. 2024;694:149468. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149468.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"6096_CR5","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1172\/jci34472","volume":"118","author":"F Sheikh","year":"2008","unstructured":"Sheikh F, Raskin A, Chu PH, Lange S, Domenighetti AA, Zheng M, et al An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J Clin Invest. 2008;118(12):3870\u201380. https:\/\/doi.org\/10.1172\/jci34472.","journal-title":"J Clin Invest"},{"issue":"3","key":"6096_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1172\/jci34450","volume":"118","author":"J Schessl","year":"2008","unstructured":"Schessl J, Zou Y, McGrath MJ, Cowling BS, Maiti B, Chin SS, et al. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest. 2008;118(3):904\u201312. https:\/\/doi.org\/10.1172\/jci34450.","journal-title":"J Clin Invest"},{"issue":"3","key":"6096_CR7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1172\/jci70108","volume":"124","author":"DC Christodoulou","year":"2014","unstructured":"Christodoulou DC, Wakimoto H, Onoue K, Eminaga S, Gorham JM, DePalma SR et al 5\u2019RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy. J Clin Invest. 2014;124(3):1364-70. https:\/\/doi.org\/10.1172\/jci70108.","journal-title":"J Clin Invest"},{"issue":"9","key":"6096_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1177\/0883073814549807","volume":"30","author":"C D\u2019Arcy","year":"2015","unstructured":"D\u2019Arcy C, Kanellakis V, Forbes R, Wilding B, McGrath M, Howell K, et al X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene. J Child Neurol. 2015;30(9):1211\u20137. https:\/\/doi.org\/10.1177\/0883073814549807.","journal-title":"J Child Neurol"},{"issue":"6","key":"6096_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/circgenetics.113.000245","volume":"6","author":"H Hartmannova","year":"2013","unstructured":"Hartmannova H, Kubanek M, Sramko M, Piherova L, Noskova L, Hodanova K, et al Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene. Circ Cardiovasc Genet. 2013;6(6):543\u201351. https:\/\/doi.org\/10.1161\/circgenetics.113.000245.","journal-title":"Circ Cardiovasc Genet"},{"key":"6096_CR10","doi-asserted-by":"publisher","first-page":"108499","DOI":"10.1016\/j.compbiomed.2024.108499","volume":"175","author":"A Khalilimeybodi","year":"2024","unstructured":"Khalilimeybodi A, Saucerman JJ, Rangamani P Modeling cardiomyocyte signaling and metabolism predicts genotype-to-phenotype mechanisms in hypertrophic cardiomyopathy. Comput Biol Med. 2024;175:108499. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108499.","journal-title":"Comput Biol Med"},{"issue":"1","key":"6096_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ana.21839","volume":"67","author":"H Knoblauch","year":"2010","unstructured":"Knoblauch H, Geier C, Adams S, Budde B, Rudolph A, Zacharias U, et al Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation. Ann Neurol. 2010;67(1):136\u201340. https:\/\/doi.org\/10.1002\/ana.21839.","journal-title":"Ann Neurol"},{"issue":"4","key":"6096_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s12551-018-0434-3","volume":"10","author":"Y Liang","year":"2018","unstructured":"Liang Y, Bradford WH, Zhang J, Sheikh F Four and a half LIM domain protein signaling and cardiomyopathy. Biophys Rev. 2018;10(4):1073\u201385. https:\/\/doi.org\/10.1007\/s12551-018-0434-3.","journal-title":"Biophys Rev"},{"issue":"3","key":"6096_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajhg.2009.07.015","volume":"85","author":"L Gueneau","year":"2009","unstructured":"Gueneau L, Bertrand AT, Jais JP, Salih MA, Stojkovic T, Wehnert M, et al Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet. 2009;85(3):338\u201353. https:\/\/doi.org\/10.1016\/j.ajhg.2009.07.015.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"6096_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ajhg.2007.09.004","volume":"82","author":"C Windpassinger","year":"2008","unstructured":"Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B, et al An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet. 2008;82(1):88\u201399. https:\/\/doi.org\/10.1016\/j.ajhg.2007.09.004.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"6096_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/circgenetics.111.962332","volume":"5","author":"JS Binder","year":"2012","unstructured":"Binder JS, Weidemann F, Schoser B, Niemann M, Machann W, Beer M, et al Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene. Circ Cardiovasc Genet. 2012;5(5):490\u2013502. https:\/\/doi.org\/10.1161\/circgenetics.111.962332.","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"6096_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/mus.23500","volume":"47","author":"T Schreckenbach","year":"2013","unstructured":"Schreckenbach T, Henn W, Kress W, Roos A, Maschke M, Feiden W, et al. Novel FHL1 mutation in a family with reducing body myopathy. Muscle Nerve. 2013;47(1):127\u201334. https:\/\/doi.org\/10.1002\/mus.23500.","journal-title":"Muscle Nerve"},{"key":"6096_CR17","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. https:\/\/doi.org\/10.1136\/bmj.g7647.","journal-title":"BMJ"},{"issue":"3","key":"6096_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/1096-8628(20001127)95:3<247::aid-ajmg12>3.0.co;2-2","volume":"95","author":"R Quadrelli","year":"2000","unstructured":"Quadrelli R, Vaglio A, Reyno S, Lemes A, Salazar D, Lachman RS, et al. Uruguay facio-cardio-musculo-skeletal syndrome: a novel X-linked recessive disorder. Am J Med Genet. 2000;95(3):247\u2009\u2212\u200965. 10.1002\/1096-8628(20001127)95:3<247::AID-AJMG12>3.0.CO;2-2.","journal-title":"Am J Med Genet"},{"issue":"2","key":"6096_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/circgenetics.115.001193","volume":"9","author":"Y Xue","year":"2016","unstructured":"Xue Y, Schoser B, Rao AR, Quadrelli R, Vaglio A, Rupp V, et al. Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death. Circ Cardiovasc Genet. 2016;9(2):130\u20135.https:\/\/doi.org\/10.1161\/circgenetics.115.001193.","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"6096_CR20","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1186\/s12881-020-01131-w","volume":"43","author":"JDS Borch","year":"2022","unstructured":"Borch JDS, Krag T, Holm-Yildiz SD, Cetin H, Solheim TA, Fornander F, et al Three novel FHL1 variants cause a mild phenotype of Emery-Dreifuss muscular dystrophy. Hum Mutat. 2022;43(9):1234\u20138. https:\/\/doi.org\/10.1186\/s12881-020-01131-w.","journal-title":"Hum Mutat"},{"issue":"8","key":"6096_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/08830738251332749","volume":"40","author":"M Finch","year":"2025","unstructured":"Finch M, Oswald S, Rao VK, Schwaede A New Clinical Phenotype in a Child Presenting With an FHL1 Mutation. J Child Neurol. 2025;40(8):696\u20139. https:\/\/doi.org\/10.1177\/08830738251332749.","journal-title":"J Child Neurol"},{"issue":"8","key":"6096_CR22","doi-asserted-by":"publisher","first-page":"e841","DOI":"10.1002\/mgg3.841","volume":"7","author":"A Gaertner-Rommel","year":"2019","unstructured":"Gaertner-Rommel A, Tiesmeier J, Jakob T, Strickmann B, Veit G, Bachmann-Mennenga B, et al Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy. Mol Genet Genomic Med. 2019;7(8):e841. https:\/\/doi.org\/10.1002\/mgg3.841.","journal-title":"Mol Genet Genomic Med"},{"key":"6096_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ijcard.2015.04.260","volume":"191","author":"M Gallego-Delgado","year":"2015","unstructured":"Gallego-Delgado M, Gonzalez-Lopez E, Garcia-Guereta L, Ortega-Molina M, Gonzalez-Vioque E, Cobo-Marcos M, et al. Adverse clinical course and poor prognosis of hypertrophic cardiomyopathy due to mutations in FHL1. Int J Cardiol. 2015;191:194\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2015.04.260.","journal-title":"Int J Cardiol"},{"issue":"1","key":"6096_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12881-020-01131-w","volume":"21","author":"A Giuc\u0103","year":"2020","unstructured":"Giuc\u0103 A, Mitu C, Popescu BO, Bastian AE, Cap\u015fa R, Murs\u0103 A, et al Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report. BMC Med Genet. 2020;21(1):188. https:\/\/doi.org\/10.1186\/s12881-020-01131-w.","journal-title":"BMC Med Genet"},{"issue":"5","key":"6096_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejmg.2013.03.001","volume":"56","author":"TD Gossios","year":"2013","unstructured":"Gossios TD, Lopes LR, Elliott PM Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1. Eur J Med Genet. 2013;56(5):251\u20135. https:\/\/doi.org\/10.1016\/j.ejmg.2013.03.001.","journal-title":"Eur J Med Genet"},{"issue":"1\u20132","key":"6096_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jns.2012.04.007","volume":"318","author":"T Komagamine","year":"2012","unstructured":"Komagamine T, Kawai M, Kokubun N, Miyatake S, Ogata K, Hayashi YK, et al Selective muscle involvement in a family affected by a second LIM domain mutation of fhl1: an imaging study using computed tomography. J Neurol Sci. 2012;318(1\u20132):163\u20137. https:\/\/doi.org\/10.1016\/j.jns.2012.04.007.","journal-title":"J Neurol Sci"},{"key":"6096_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2022.04.006","author":"M L\u00f3pez Bl\u00e1zquez","year":"2022","unstructured":"L\u00f3pez Bl\u00e1zquez M, Fern\u00e1ndez \u00c1vila AI, \u00c1lvarez, Garc\u00eda-Rov\u00e9s R, Centeno Jim\u00e9nez M, G\u00f3mez Gonz\u00e1lez C, Espinosa Castro M Description of a novel variant in the FHL1 gene associated with hypertrophic cardiomyopathy with early and aggressive presentation. Rev Esp Cardiol (Engl Ed). 2022;75(11):968\u2009\u2013\u200970. https:\/\/doi.org\/10.1016\/j.rec.2022.04.006.","journal-title":"Rev Esp Cardiol"},{"issue":"3","key":"6096_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/cnd.0000000000000518","volume":"26","author":"CB Nagaraj","year":"2025","unstructured":"Nagaraj CB, Tian C, Kushlaf H. RNA Sequencing Confirms the Pathogenicity of a Novel FHL1 Deletion in a Kinship With Emery-Dreifuss Muscular Dystrophy. J Clin Neuromuscul Dis. 2025;26(3):148\u201351. https:\/\/doi.org\/10.1097\/cnd.0000000000000518.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"4","key":"6096_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejmg.2015.02.003","volume":"58","author":"AE Pen","year":"2015","unstructured":"Pen AE, Nyegaard M, Fang M, Jiang H, Christensen R, M\u00f8lgaard H, et al A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology. Eur J Med Genet. 2015;58(4):222\u20139. https:\/\/doi.org\/10.1016\/j.ejmg.2015.02.003.","journal-title":"Eur J Med Genet"},{"issue":"2","key":"6096_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10048-013-0359-8","volume":"14","author":"HR Tiffin","year":"2013","unstructured":"Tiffin HR, Jenkins ZA, Gray MJ, Cameron-Christie SR, Eaton J, Aftimos S, et al Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype. Neurogenetics. 2013;14(2):113\u201321. https:\/\/doi.org\/10.1007\/s10048-013-0359-8.","journal-title":"Neurogenetics"},{"issue":"2","key":"6096_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/cge.12695","volume":"90","author":"TA Willis","year":"2016","unstructured":"Willis TA, Wood CL, Hudson J, Polvikoski T, Barresi R, Lochm\u00fcller H, et al Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion. Clin Genet. 2016;90(2):166\u201370. https:\/\/doi.org\/10.1111\/cge.12695.","journal-title":"Clin Genet"},{"issue":"16","key":"6096_CR32","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.4103\/0366-6999.162493","volume":"128","author":"BQ Zhang","year":"2015","unstructured":"Zhang BQ, Si N, Liu DF Identification of a Novel Four and a Half LIM Domain 1 Mutation in a Chinese Male Presented with Hypertrophic Cardiomyopathy and Mild Skeletal Muscle Hypertrophy. Chin Med J (Engl). 2015;128(16):2269\u201370. https:\/\/doi.org\/10.4103\/0366-6999.162493.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"6096_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/cge.12760","volume":"90","author":"I San Rom\u00e1n","year":"2016","unstructured":"San Rom\u00e1n I, Navarro M, Mart\u00ednez F, Albert L, Polo L, Guardiola J, et al Unclassifiable arrhythmic cardiomyopathy associated with Emery-Dreifuss caused by a mutation in FHL1. Clin Genet. 2016;90(2):171\u20136. https:\/\/doi.org\/10.1111\/cge.12760.","journal-title":"Clin Genet"},{"issue":"1","key":"6096_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/hmg\/ddt412","volume":"23","author":"AA Domenighetti","year":"2013","unstructured":"Domenighetti AA, Chu P-H, Wu T, Sheikh F, Gokhin DS, Guo LT, et al Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice. Hum Mol Genet. 2013;23(1):209\u201325. https:\/\/doi.org\/10.1093\/hmg\/ddt412.","journal-title":"Hum Mol Genet"},{"issue":"Pt 10","key":"6096_CR35","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1242\/jcs.140905","volume":"127","author":"BR Wilding","year":"2014","unstructured":"Wilding BR, McGrath MJ, Bonne G, Mitchell CA FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation. J Cell Sci. 2014;127(Pt 10):2269\u201381. https:\/\/doi.org\/10.1242\/jcs.140905.","journal-title":"J Cell Sci"},{"issue":"35","key":"6096_CR36","doi-asserted-by":"publisher","first-page":"29273","DOI":"10.1074\/jbc.M112.372839","volume":"287","author":"A Raskin","year":"2012","unstructured":"Raskin A, Lange S, Banares K, Lyon RC, Zieseniss A, Lee LK, et al. A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics. J Biol Chem. 2012;287(35):29273\u201384.","journal-title":"J Biol Chem"},{"issue":"5","key":"6096_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","volume":"59","author":"IA van Rijsingen","year":"2012","unstructured":"van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der Kooi AJ, et al Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59(5):493\u2013500. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.078.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6096_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-0004.2010.01512.x","volume":"80","author":"KY van Spaendonck-Zwarts","year":"2011","unstructured":"van Spaendonck-Zwarts KY, van Hessem L, Jongbloed JD, de Walle HE, Capetanaki Y, van der Kooi AJ, et al Desmin-related myopathy. Clin Genet. 2011;80(4):354\u201366. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01512.x.","journal-title":"Clin Genet"},{"issue":"1","key":"6096_CR39","doi-asserted-by":"publisher","first-page":"e003121","DOI":"10.1161\/circep.115.003121","volume":"9","author":"AG Porto","year":"2016","unstructured":"Porto AG, Brun F, Severini GM, Losurdo P, Fabris E, Taylor MRG, et al Clinical Spectrum of PRKAG2 Syndrome. Circ Arrhythm Electrophysiol. 2016;9(1):e003121. https:\/\/doi.org\/10.1161\/circep.115.003121.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"37","key":"6096_CR40","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503\u2013626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194.","journal-title":"Eur Heart J"},{"issue":"9","key":"6096_CR41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/NEN.0b013e3182a23506","volume":"72","author":"E Malfatti","year":"2013","unstructured":"Malfatti E, Oliv\u00e9 M, Taratuto AL, Richard P, Brochier G, Bitoun M, et al Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders. J Neuropathol Exp Neurol. 2013;72(9):833\u201345. https:\/\/doi.org\/10.1097\/NEN.0b013e3182a23506.","journal-title":"J Neuropathol Exp Neurol"},{"key":"6096_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2014.02.002","author":"AT Bertrand","year":"2014","unstructured":"Bertrand AT, B\u00f6nnemann CG, Bonne G 199th ENMC international workshop: FHL1 related myopathies, June 7\u20139, 2013, Naarden, The Netherlands. Neuromuscul Disord. 2014;24(5):453\u2009\u2013\u200962. https:\/\/doi.org\/10.1016\/j.nmd.2014.02.002.","journal-title":"Neuromuscul Disord"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06096-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:57:08Z","timestamp":1781665028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06096-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6096"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06096-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics of approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"518"}}